Retail Pharmacy Set to Buck Tough Election Year

A conundrum of regulatory issues and decisions in coming months threaten to stifle community retail pharmacy’s goal of advancing patient access to health care services designed to lower overall costs. 

These include anticompetitive practices of third-party pharmacy benefit management (PBM) companies, federal and state cuts to pharmacy reimbursement rates, drug safety issues and access to Medication Therapy Management services.

First off there is the $29 billion Ex

Register to view the full article

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.